The trade group says the denial does not settle its concerns about a law that limits minors' access to supplements marketed for weight loss or muscle building, and the case now returns to district court.
|Articles|April 17, 2013
SupplySide Marketplace Preview: PhosphoLean NOPE+EGCG
PhosphoLean NOPE + EGCG is a patented appetite suppressant compound that is clinically proven to help people stay on their diets.
Advertisement
PhosphoLean NOPE + EGCG is a patented appetite suppressant compound that is clinically proven to help people stay on their diets. PhosphoLean signals the brain to switch off the sensations of hunger and helps individuals manage their stressful diets and lower diet depression. PhosphoLean can be a keynote ingredient for a company’s next weight-management product.
Booth 138
Advertisement
Related to this article
Women are the predominant users of these drugs, and the authors say guidance has not kept pace, with nutrient gaps and supplement support also in focus.
Trade groups say the law's broad criteria could restrict access to supplements with uses beyond weight loss or muscle building.
At The Outlook on Active Nutrition, Doug Kalman, PhD, RD, FISSN, outlines where GLP-1 drugs are falling short, and where nutraceutical brands can step in.
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
Powerful Plants
2
Beyond the Symptom: How Botanicals Are Redefining the Sleep Health Category
3
Olly Launches Mochi Bites Supplements in Beauty, Sleep, Multi, and Energy
4
PhytoGaia Brings Pet Wellness, Liver Research, and Product Concepts to SupplySide Global
5